Literature DB >> 29652619

Circulating Cytokine/Chemokine Concentrations Respond to Ionizing Radiation Doses but not Radiation Dose Rates: Granulocyte-Colony Stimulating Factor and Interleukin-18.

Juliann G Kiang1,2,3, Joan T Smith1, Sara R Hegge4, Natalia I Ossetrova5.   

Abstract

Exposure to ionizing radiation is a crucial life-threatening factor in nuclear and radiological incidents. It is known that ionizing radiation affects cytokine/chemokine concentrations in the blood of B6D2F1 mice. It is not clear whether radiation dose rates would vary the physiological response. Therefore, in this study we utilized data from two experiments using B6D2F1 female mice exposed to six different dose rates ranging from low to high rates. In one experiment, mice received a total dose of 8 Gy (LD0/30) of 60Co gamma radiation at four dose rates: 0.04, 0.15, 0.30 and 0.47 Gy/min. Blood samples from mice were collected at 24 and 48 h postirradiation for cytokine/chemokine measurements, including interleukin (IL)-1β, IL-6, IL-10, keratinocyte cytokine (KC), IL-12p70, IL-15, IL-17A, IL-18, granulocyte-colony stimulating factor (G-CSF), granulocyte macrophage (GM)-CSF, macrophage (M)-CSF, monokine induced by gamma interferon (MIG), tumor necrosis factor (TNF)-α, fibroblast growth factor (FGF)-basic, vascular endothelial growth factor (VEGF) and platelet-derived growth factor basic (PDGF-bb). At 24 h after ionizing irradiation at dose rate of 0.04 Gy/min, significant increases were observed only in G-CSF and M-CSF ( P < 0.05). At 0.15 Gy/min, IL-10, IL-17A, G-CSF and GM-CSF concentrations were increased. At 0.3 Gy/min, IL-15, IL-18, G-CSF, GM-CSF, M-CSF, MCP-1, MIP-2, MIG, FGF-basic, VEGF and PDGF-bb were significantly elevated ( P < 0.05). At 0.47 Gy/min, IL-6, KC, IL-10, MCP-1, G-CSF, GM-CSF and M-CSF were significantly increased. At 48 h postirradiation, all cytokines/chemokines except MCP-1 returned to or were below their baselines, suggesting these increases are transient at LD0/30 irradiation. Of note, there is a limitation on day 2 because cytokines/chemokines are either at or below their baselines. Other parameters such as fms-like tyrosine kinase receptor-3 ligand (Flt-3 ligand) concentrations and lymphocyte counts, which have proven to be unaffected by radiation dose rates, can be used instead for assessing the radiation dose. However, in a separate radiation dose and time-course experiment, increases in IL-18 and G-CSF depended on the radiation doses but showed no significant differences between 0.58 and 1.94 Gy/min ( P > 0.05) at 3 and 6 Gy but not 12 Gy. G-CSF continued to increase up to day 7, whereas IL-18 increased on day 4 and remained above baseline level on day 7. Therefore, time after irradiation at different doses should be taken into consideration. To our knowledge, these results are the first to suggest that ionizing radiation, even at a very low-dose-rate (0.04 Gy/min), induces circulating G-CSF increases but not others for selected time points; radiation-induced increases in IL-18 at radiation dose rates between 0.15 and 1.94 Gy/min are also not in a radiation dose-rate-dependent manner. C-CSF, lymphocyte counts and circulating Flt-3 ligand should be explored further as possible biomarkers of radiation exposure at early time points. IL-18 is also worthy of further study as a potential biomarker at later time points.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29652619     DOI: 10.1667/RR14966.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  8 in total

1.  Neutron Radiobiology and Dosimetry.

Authors:  Daniela L Stricklin; Jama VanHorne-Sealy; Carmen I Rios; Lisa A Scott Carnell; Lanyn P Taliaferro
Journal:  Radiat Res       Date:  2021-05-01       Impact factor: 2.841

2.  Female Mice are More Resistant to the Mixed-Field (67% Neutron + 33% Gamma) Radiation-Induced Injury in Bone Marrow and Small Intestine than Male Mice due to Sustained Increases in G-CSF and the Bcl-2/Bax Ratio and Lower miR-34a and MAPK Activation.

Authors:  Juliann G Kiang; Georgetta Cannon; Matthew G Olson; Joan T Smith; Marsha N Anderson; Min Zhai; M Victoria Umali; Kevin Ho; Connie Ho; Wanchang Cui; Mang Xiao
Journal:  Radiat Res       Date:  2022-08-01       Impact factor: 3.372

3.  RRx-001 Radioprotection: Enhancement of Survival and Hematopoietic Recovery in Gamma-Irradiated Mice.

Authors:  Kimberly J Jurgensen; William K J Skinner; Bryan Oronsky; Nacer D Abrouk; Andrew E Graff; Reid D Landes; William E Culp; Thomas A Summers; Lynnette H Cary
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

4.  Ghrelin, a novel therapy, corrects cytokine and NF-κB-AKT-MAPK network and mitigates intestinal injury induced by combined radiation and skin-wound trauma.

Authors:  Juliann G Kiang; Joan T Smith; Georgetta Cannon; Marsha N Anderson; Connie Ho; Min Zhai; Wanchang Cui; Mang Xiao
Journal:  Cell Biosci       Date:  2020-05-12       Impact factor: 7.133

5.  Ionizing radiation exposure of stem cell-derived chondrocytes affects their gene and microRNA expression profiles and cytokine production.

Authors:  Ewelina Stelcer; Katarzyna Kulcenty; Marcin Rucinski; Marta Kruszyna-Mochalska; Agnieszka Skrobala; Agnieszka Sobecka; Karol Jopek; Wiktoria Maria Suchorska
Journal:  Sci Rep       Date:  2021-04-05       Impact factor: 4.379

6.  Haptoglobin is an early indicator of survival after radiation-induced severe injury and bone marrow transplantation in mice.

Authors:  Shixiang Zhou; Yaqiong Li; Lexin He; Min Chen; Weihong Li; Ting Xiao; Jian Guan; Zhenhua Qi; Qi Wang; Siyuan Li; Pingkun Zhou; Zhidong Wang
Journal:  Stem Cell Res Ther       Date:  2022-09-06       Impact factor: 8.079

7.  Boswellic Acid Synergizes With Low-Level Ionizing Radiation to Modulate Bisphenol Induced-Lung Toxicity in Rats by Inhibiting JNK/ERK/c-Fos Pathway.

Authors:  Somya Z Mansour; Fatma S M Moawed; Monda M M Badawy; Hebatallah E Mohamed
Journal:  Dose Response       Date:  2020-10-30       Impact factor: 2.658

Review 8.  COVID-19: Proposing a Ketone-Based Metabolic Therapy as a Treatment to Blunt the Cytokine Storm.

Authors:  Patrick C Bradshaw; William A Seeds; Alexandra C Miller; Vikrant R Mahajan; William M Curtis
Journal:  Oxid Med Cell Longev       Date:  2020-09-09       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.